|
|
||||||||
EDUCATION EXHIBIT |
From the Department of Radiology and Center for Imaging Science (S.C., D.C., S.J.L., W.J.L., M.P., S.W.K.) and the Department of Diagnostic Pathology (D.K.L., K.-T.J.), Samsung Medical Center, Sungkyunkwan University School of Medicine, 50, Ilwon-Dong, Kangnam-Ku, Seoul 135-710, South Korea. Presented as an education exhibit at the 2005 RSNA Annual Meeting. Received January 4, 2007; revision requested February 5 and received March 15; accepted March 16. All authors have no financial relationships to disclose. Address correspondence to D.C. (e-mail: dichoi{at}smc.samsung.co.kr).
Many radiologists are unfamiliar with the recently developed World Health Organization classification scheme for neuroendocrine tumors. According to this classification scheme, neuroendocrine tumors are divided into well-differentiated endocrine tumors (carcinoids), well-differentiated endocrine carcinomas (malignant carcinoids), and poorly differentiated endocrine carcinomas on the basis of their location, histologic features, and biologic behavior.
Neuroendocrine tumors of the gastrointestinal tract originate from the cells derived from the embryonic neural crest, neuroectoderm, and endoderm. They usually produce bioactive substances and show immunoreactivity to neuroendocrine markers.
© RSNA, 2007
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOGRAPHICS | RADIOLOGY | RSNA JOURNALS ONLINE |